Cephalon, Beijing Med-Pharm deal

BJGP will develop and register CEPH's Fentora fentanyl effervescent buccal tablet (FEBT) in China to treat breakthrough pain in opioid-tolerant cancer patients. BJGP plans to conduct a Chinese regis...